Abstract
We have compared, in 60 adult patients, the cardiovascular effects of glycopyrronium 5 μg kg-1 and 10 μg kg-1 given either simultaneously or 1 min before edrophonium 1 μg kg-1. Significant differences between the four groups were detected (P < 0.001). Both groups receiving 10 μg kg-1 showed increases in heart rate of up to 30 beat min-1 (95% confidence limits 28-32 beat min-1). Use of glycopyrronium 5 μg kg-1 provided greater cardiovascular stability and, given 1 min before the edrophonium, was sufficient to minimize early, edrophonium-induced bradycardias. This low dose of glycoprronium provided good control of oropharyngeal secretions. © 1989 British Journal of Anaesthesia.
Cite
CITATION STYLE
Dodd, P., Day, S. J., Goldhill, D. R., Macleod, D. M., Withington, P. S., & Yate, P. M. (1989). Glycopyrronium requirements for antagonism of the muscarinic side effects of edrophonium†. British Journal of Anaesthesia, 62(1), 77–81. https://doi.org/10.1093/bja/62.1.77
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.